178.46
price down icon0.08%   -0.1335
 
loading
Schlusskurs vom Vortag:
$178.59
Offen:
$178.35
24-Stunden-Volumen:
683.42K
Relative Volume:
0.43
Marktkapitalisierung:
$9.32B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$207.70M
KGV:
-64.35
EPS:
-2.7734
Netto-Cashflow:
$193.10M
1W Leistung:
+0.64%
1M Leistung:
+1.73%
6M Leistung:
+20.47%
1J Leistung:
+23.58%
1-Tages-Spanne:
Value
$178.19
$178.50
1-Wochen-Bereich:
Value
$176.94
$178.65
52-Wochen-Spanne:
Value
$125.94
$179.00

Masimo Corp Stock (MASI) Company Profile

Name
Firmenname
Masimo Corp
Name
Telefon
949-297-7000
Name
Adresse
52 DISCOVERY, IRVINE, CA
Name
Mitarbeiter
2,200
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
MASI's Discussions on Twitter

Compare MASI vs ABT, SYK, MDT, BSX, EW

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
MASI icon
MASI
Masimo Corp
178.46 9.32B 1.53B 207.70M 193.10M -2.7734
ABT icon
ABT
Abbott Laboratories
102.04 178.75B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
331.83 126.97B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
86.19 111.22B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
62.50 93.36B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
81.02 46.73B 6.07B 1.06B 1.34B 1.8063

Masimo Corp Stock (MASI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-03-27 Herabstufung Raymond James Outperform → Mkt Perform
2025-11-17 Eingeleitet BofA Securities Neutral
2024-12-27 Bestätigt Raymond James Outperform
2024-11-06 Hochstufung Raymond James Mkt Perform → Outperform
2024-06-03 Hochstufung Piper Sandler Neutral → Overweight
2024-04-15 Hochstufung Stifel Hold → Buy
2024-03-25 Hochstufung Wells Fargo Equal Weight → Overweight
2024-01-30 Herabstufung Jefferies Buy → Hold
2024-01-03 Herabstufung Needham Buy → Hold
2023-11-08 Herabstufung Raymond James Outperform → Mkt Perform
2023-07-18 Herabstufung Stifel Buy → Hold
2023-07-10 Eingeleitet Wells Fargo Equal Weight
2023-02-22 Hochstufung Raymond James Mkt Perform → Outperform
2022-12-15 Hochstufung BTIG Research Neutral → Buy
2022-12-05 Bestätigt Needham Buy
2022-10-12 Eingeleitet Jefferies Buy
2022-09-15 Hochstufung Wolfe Research Peer Perform → Outperform
2022-09-14 Eingeleitet Loop Capital Buy
2022-04-06 Eingeleitet Wolfe Research Peer Perform
2022-02-18 Hochstufung Needham Hold → Buy
2022-02-16 Herabstufung Piper Sandler Overweight → Neutral
2021-10-12 Fortgesetzt Raymond James Mkt Perform
2020-09-02 Eingeleitet Robert W. Baird Outperform
2020-08-14 Fortgesetzt Piper Sandler Overweight
2020-04-20 Herabstufung Needham Buy → Hold
2020-03-02 Hochstufung Raymond James Mkt Perform → Outperform
2019-05-07 Bestätigt Needham Buy
2019-04-16 Herabstufung BTIG Research Buy → Neutral
2019-03-13 Bestätigt Needham Buy
2018-12-19 Hochstufung Piper Jaffray Neutral → Overweight
2018-09-14 Eingeleitet Needham Buy
2018-03-09 Eingeleitet Barclays Overweight
2017-08-14 Hochstufung BTIG Research Neutral → Buy
2017-04-04 Bestätigt Wedbush Outperform
2017-03-16 Herabstufung Piper Jaffray Overweight → Neutral
2017-02-27 Bestätigt Wedbush Outperform
2017-02-13 Herabstufung Raymond James Outperform → Mkt Perform
2016-08-04 Bestätigt Wedbush Outperform
2016-05-05 Hochstufung Piper Jaffray Neutral → Overweight
2016-05-05 Bestätigt Wedbush Outperform
2016-01-06 Herabstufung Raymond James Strong Buy → Outperform
2015-08-05 Bestätigt ROTH Capital Buy
Alle ansehen

Masimo Corp Aktie (MASI) Neueste Nachrichten

pulisher
Apr 05, 2026

Wealth Enhancement Advisory Services LLC Raises Stake in Masimo Corporation $MASI - MarketBeat

Apr 05, 2026
pulisher
Apr 05, 2026

SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI - MarketBeat

Apr 05, 2026
pulisher
Apr 02, 2026

Masimo Corporation (MASI) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 02, 2026

Masimo Corporation (MASI) Stock forecasts - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 01, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Masimo (MASI) agrees to $180 cash takeover by Danaher; vote set May 1, 2026 - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

Quinn Emanuel disqualified in Masimo board dispute - Daily Journal

Mar 31, 2026
pulisher
Mar 30, 2026

Quinn Emanuel Disqualified from Masimo Board Fight with Founder - National Today

Mar 30, 2026
pulisher
Mar 30, 2026

Quinn Emanuel Disqualified From Masimo Board Fight With Founder - Bloomberg Law News

Mar 30, 2026
pulisher
Mar 29, 2026

Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - AD HOC NEWS

Mar 29, 2026
pulisher
Mar 29, 2026

Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat

Mar 29, 2026
pulisher
Mar 28, 2026

Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat

Mar 28, 2026
pulisher
Mar 28, 2026

Masimo Corp at JPMorgan Healthcare Conference Transcript - gurufocus.com

Mar 28, 2026
pulisher
Mar 28, 2026

Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS

Mar 28, 2026
pulisher
Mar 27, 2026

Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald

Mar 27, 2026
pulisher
Mar 27, 2026

The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Masimo downgraded to Market Perform from Outperform at Raymond James - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

Masimo (NASDAQ:MASI) Rating Lowered to Market Perform at Raymond James Financial - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Raymond James downgrades Masimo stock rating on Danaher deal By Investing.com - Investing.com India

Mar 27, 2026
pulisher
Mar 27, 2026

Masimo Corporation $MASI Shares Sold by JPMorgan Chase & Co. - marketbeat.com

Mar 27, 2026
pulisher
Mar 27, 2026

Raymond James downgrades Masimo stock rating on Danaher deal - Investing.com

Mar 27, 2026
pulisher
Mar 27, 2026

Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Mar 27, 2026
pulisher
Mar 26, 2026

MASI PE Ratio & Valuation, Is MASI Overvalued - Intellectia AI

Mar 26, 2026
pulisher
Mar 26, 2026

Tudor Investment Corp ET AL Buys New Holdings in Masimo Corporation $MASI - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

Masimo Corporation (MASI) Stock Forecasts - Yahoo Finance

Mar 25, 2026
pulisher
Mar 25, 2026

Masimo MightySat Medical Fingertip Pulse Oximeter: Precision Health Monitoring for Home and Clinical - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 24, 2026

Danaher said to near $10 billion deal for Masimo, FT reports - MSN

Mar 24, 2026
pulisher
Mar 24, 2026

Masimo (NASDAQ:MASI) Reaches New 12-Month HighTime to Buy? - MarketBeat

Mar 24, 2026
pulisher
Mar 22, 2026

This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - Yahoo Finance

Mar 22, 2026
pulisher
Mar 22, 2026

Masimo's Patient Monitoring Innovations Drive Growth in Wearable Health Tech for DACH Markets - AD HOC NEWS

Mar 22, 2026
pulisher
Mar 21, 2026

Masimo's Latest Health Monitoring Receivers Advance Wearable Audio Integration for DACH Consumers - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 20, 2026

MASI Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 20, 2026
pulisher
Mar 19, 2026

Apple fends off bid for new Apple Watch import ban at US trade tribunal - Reuters

Mar 19, 2026
pulisher
Mar 19, 2026

Masimo (NASDAQ:MASI) Upgraded at Wells Fargo & Company - MarketBeat

Mar 19, 2026
pulisher
Mar 18, 2026

Apple Took Masimo IP But No Remedy Warranted, Judge Says - Law360

Mar 18, 2026
pulisher
Mar 18, 2026

Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Masimo (NASDAQ:MASI) Sets New 52-Week HighShould You Buy? - MarketBeat

Mar 18, 2026
pulisher
Mar 17, 2026

Masimo Corporation stock hits 52-week high at $175.91 - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Masimo Corporation stock hits 52-week high at $175.91 By Investing.com - Investing.com Canada

Mar 17, 2026
pulisher
Mar 17, 2026

Masimo (NASDAQ:MASI) Sees Large Volume IncreaseTime to Buy? - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

Danaher to acquire Irvine-based Masimo - Irvine Standard

Mar 16, 2026
pulisher
Mar 16, 2026

Masimo (MASI) CFO exercises RSUs, retains shares after tax withholding - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? – Company Announcement - Financial Times

Mar 16, 2026
pulisher
Mar 16, 2026

MASIMO (MASI) CEO Szyman exercises RSUs, withholds shares to cover tax - Stock Titan

Mar 16, 2026
pulisher
Mar 15, 2026

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement - Yahoo Finance

Mar 15, 2026
pulisher
Mar 14, 2026

Masimo Corporation $MASI Shares Purchased by Squarepoint Ops LLC - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Onex Canada Asset Management Inc. Has $4.12 Million Stake in Masimo Corporation $MASI - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com

Mar 14, 2026
pulisher
Mar 13, 2026

Politan-linked funds structure MASIMO (MASI) forward sales over 273,550 shares - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

12,025 Shares in Masimo Corporation $MASI Bought by Quantitative Investment Management LLC - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Danaher Corp. Stock (ISIN: US2358511028) Slides Amid Masimo Acquisition Scrutiny and Conservative Gu - AD HOC NEWS

Mar 13, 2026

Finanzdaten der Masimo Corp-Aktie (MASI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Masimo Corp-Aktie (MASI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Young Micah W
EVP & Chief Financial Officer
Mar 11 '26
Option Exercise
0.00
873
0
26,127
Szyman Catherine M.
CEO
Feb 12 '26
Option Exercise
132.96
11,141
1,481,307
11,141
Sampath Anand
EVP, Ops & Clinical Research
Jan 28 '26
Option Exercise
37.84
30,000
1,135,200
59,589
Sampath Anand
EVP, Ops & Clinical Research
Jan 28 '26
Sale
136.81
18,680
2,555,570
40,909
ZBH ZBH
$90.66
price down icon 0.25%
STE STE
$219.63
price up icon 0.37%
$62.30
price down icon 0.24%
PHG PHG
$27.18
price up icon 0.28%
$70.34
price down icon 0.01%
EW EW
$81.05
price down icon 0.06%
Kapitalisierung:     |  Volumen (24h):